Obsessive Compulsive Disorder: Clinical Trials

13 trials for Obsessive Compulsive Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 13
Phase 11Completed 1

Follow Obsessive Compulsive Disorder: new trials by email Literature Review of Obsessive Compulsive Disorder trials Research Report on Obsessive Compulsive Disorder

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
Minocycline, Placebo - Obsessive Compulsive Disorder
Phase 2CompletedNew York State Psychiatric Institute312012-05-012019-11-13
Efficacy Study of Transcranial Magnetic Stimulation for Treatment of Obsessive-Compulsive Disorder
Repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive transcranial magnetic stimulation - Obsessive Compulsive Disorder
Phase 2CompletedUniversity of Brasilia222011-05-012012-02-28
Internet-based Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)
Internet-based cognitive behavior therapy, Support therapy on Internet - Obsessive Compulsive Disorder
Phase 2CompletedKarolinska Institutet1012011-02-012018-03-21
Exercise and Health Intervention for Patients With Obsessive Compulsive Disorder (OCD)
Aerobic exercise, Health and Wellness - Obsessive Compulsive Disorder
Phase 2CompletedButler Hospital562010-11-012015-07-22
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
Agomelatine A, Placebo - Obsessive Compulsive Disorder
Phase 2CompletedInstitut de Recherches Internationales Servier742010-05-012024-07-25
Marinol in Trichotillomania or Obsessive Compulsive Disorder
Dronabinol - Trichotillomania, Obsessive Compulsive Disorder
Phase 2CompletedUniversity of Chicago142010-04-012023-02-23
Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
Cognitive-behavioral therapy, Wait-list control - Obsessive Compulsive Disorder
Phase 2CompletedUniversity of South Florida312009-03-012015-06-11
Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)
NPL-2003 - Obsessive Compulsive Disorder
Phase 2CompletedNew York State Psychiatric Institute92008-08-012012-04-02
N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
N-methyl glycine - Obsessive Compulsive Disorder
Phase 2CompletedChina Medical University Hospital302007-06-012009-12-29
Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)
deep brain stimulation, No stimulation - Obsessive Compulsive Disorder
Phase 1 / Phase 2CompletedMarie-laure Welter162005-10-012018-03-22
Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
Quetiapine - Obsessive Compulsive Disorder
Phase 2CompletedAstraZeneca902003-12-012011-01-21
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
St. John's Wort - Obsessive Compulsive Disorder
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)602002-05-012006-08-04
Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
Penicillin or Placebo - Mental Disorder Diagnosed in Childhood, Obsessive Compulsive Disorder
Phase 2CompletedNational Institute of Mental Health (NIMH)901993-04-012008-03-04

Narrower conditions

Obsessive-Compulsive Disorder (13)  ·  Anxiety Disorders (1)  ·  Compulsive Personality Disorder (1)  ·  Excoriation Disorder (1)  ·  Motor Activity (1)  ·  Psychological Well-Being (1)  ·  Streptococcal Infections (1)  ·  Tic Disorders (1)  ·  Trichotillomania (1)

Broader conditions

Mental Disorders (13)  ·  Anxiety Disorders (12)  ·  Behavior (3)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Behavioral Symptoms (1)  ·  Central Nervous System Diseases (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodevelopmental Disorders (1)  ·  Personal Satisfaction (1)  ·  Personality Disorders (1)

Interventions

Cognitive Behavioral Therapy (1)  ·  Deep Brain Stimulation (1)  ·  Dronabinol (1)  ·  Exercise (1)  ·  Health (1)  ·  Hypericum extract LI 160 (1)  ·  Minocycline (1)  ·  Penicillins (1)  ·  Quetiapine Fumarate (1)  ·  Sarcosine (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

New York State Psychiatric Institute (2)  ·  AstraZeneca (1)  ·  Butler Hospital (1)  ·  China Medical University Hospital (1)  ·  Institut de Recherches Internationales Servier (1)  ·  Karolinska Institutet (1)  ·  Marie-laure Welter (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  University of Brasilia (1)  ·  University of Chicago (1)  ·  University of South Florida (1)

Countries

United States (7)  ·  Brazil (1)  ·  France (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Ana M Abrantes, Ph.D. (1)  ·  Carolyn I. Rodriguez, M.D., Ph.D. (1)  ·  Eric Storch, Ph.D. (1)  ·  Guochuan E Tsai, MD, PhD (1)  ·  Joaquim Brasil-Neto, MD, PhD (1)  ·  Jon E Grant, JD, MD, MPH (1)  ·  Joseph Zohar, Prof. (1)  ·  Kenneth Kobak, PhD (1)  ·  Leslie Taylo, MD (1)  ·  Luc Mallet, MD, PhD (1)  ·  Moira A Rynn, M.D. (1)

Results publications

PMID 19005196, PMID 20621362, PMID 20923629, PMID 20951978, PMID 21590520, PMID 22348650, PMID 37330252

NIH funding

2009 (1), R01MH086513 (1), R34MH095502 (1)